Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is InterMedical Care and Lab Hospital PCL Cash-to-Debt?
InterMedical Care and Lab Hospital PCLBKK:IMH-R 70 Cash-to-Debt is 0.01 as of Jun. 2026, which is 98% below its 10-year median of 0.46. GuruFocus rates BKK:IMH-R with a GF Score™ of 70/100 and a GF Value™ of ฿5.85 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 671 Healthcare Providers & Services companies, InterMedical Care and Lab Hospital PCL ranks worse than 98.51% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. InterMedical Care and Lab Hospital PCL's cash to debt ratio for the quarter that ended in Jun. 2026 was 0.01.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, InterMedical Care and Lab Hospital PCLcouldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2026.
BKK:IMH-R's Cash-to-Debt is ranked worse than 98.51% of 671
companies
in the Healthcare Providers & Services industry
Industry Median: 0.79
vs BKK:IMH-R: 0.01
InterMedical Care and Lab Hospital PCL (BKK:IMH-R) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
InterMedical Care and Lab Hospital PCL Cash-to-Debt Related Terms
InterMedical Care and Lab Hospital PCL Cash-to-Debt Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
InterMedical Care and Lab Hospital PCL Cash-to-Debt Chart
InterMedical Care and Lab Hospital PCL Annual Data
BKK:IMH-R vs HCA, THC, EHC: Cash-to-Debt Comparison
For the Medical Care Facilities subindustry, InterMedical Care and Lab Hospital PCL's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InterMedical Care and Lab Hospital PCL Cash-to-Debt vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, InterMedical Care and Lab Hospital PCL's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where InterMedical Care and Lab Hospital PCL's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InterMedical Care and Lab Hospital PCL (BKK:IMH-R) has a Cash-to-Debt of 0.01 as of Jun. 2026. This is 98% below median its historical median of 0.46. Over the past decade, InterMedical Care and Lab Hospital PCL's Cash-to-Debt has ranged from 0.01 to 28.61. According to the industry distribution chart, InterMedical Care and Lab Hospital PCL ranks #661 out of 671 companies in the Healthcare Providers & Services industry, placing it in the top 98.5%.
Is InterMedical Care and Lab Hospital PCL's Cash-to-Debt too high?
InterMedical Care and Lab Hospital PCL's current Cash-to-Debt of 0.01 is 98% below median its 10-year median of 0.46. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 28.61. The Healthcare Providers & Services industry median Cash-to-Debt is 0.79. InterMedical Care and Lab Hospital PCL's value of 0.01 is 98.7% below this industry median. Based on the distribution chart, InterMedical Care and Lab Hospital PCL ranks #661 out of 671 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, InterMedical Care and Lab Hospital PCL has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does InterMedical Care and Lab Hospital PCL's Cash-to-Debt compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, InterMedical Care and Lab Hospital PCL ranks #661 out of 671 companies for Cash-to-Debt. This places InterMedical Care and Lab Hospital PCL in the lower half of its industry. The industry median Cash-to-Debt is 0.79. InterMedical Care and Lab Hospital PCL's value of 0.01 is 98.7% below this benchmark. Historically, InterMedical Care and Lab Hospital PCL's own Cash-to-Debt has ranged from 0.01 to 28.61 over the past decade. While the company's 10-year median is 0.46 vs. the industry median of 0.79, InterMedical Care and Lab Hospital PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Healthcare Providers & Services company?
The median Cash-to-Debt among Healthcare Providers & Services companies is 0.79, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InterMedical Care and Lab Hospital PCL's current Cash-to-Debt of 0.01 is 98.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Cash-to-Debt is 0.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InterMedical Care and Lab Hospital PCL's current Cash-to-Debt is 0.01, which is 98% below median its own 10-year median of 0.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InterMedical Care and Lab Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, InterMedical Care and Lab Hospital PCL (BKK:IMH-R) is currently considered Possible Value Trap. The stock's GF Value™ is ฿5.85, compared to a current price of ฿3.62 — trading 38.1% below its estimated fair value. The current Cash-to-Debt is 0.01, which is 98% below median its 10-year median of 0.46 and 98.7% below the Healthcare Providers & Services industry median of 0.79. InterMedical Care and Lab Hospital PCL's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For InterMedical Care and Lab Hospital PCL (BKK:IMH-R), the current Cash-to-Debt is 0.01 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InterMedical Care and Lab Hospital PCL (BKK:IMH-R) Overvalued in 2026?
Based on GuruFocus' analysis, InterMedical Care and Lab Hospital PCL stock appears to be undervalued.
The current stock price of ฿3.62 is trading 38.1% below its estimated GF Value™ of ฿5.85.
GuruFocus considers InterMedical Care and Lab Hospital PCL to be Possible Value Trap.
Key valuation signals for BKK:IMH-R:
Cash-to-Debt: 0.01 (98% below median its 10-year median of 0.46)
GF Value™: ฿5.85 vs. price of ฿3.62 (38.1% below fair value)
Industry Position: 98.7% below the Healthcare Providers & Services median (#661 of 671)
No single metric tells the full story. See the BKK:IMH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InterMedical Care and Lab Hospital PCL is a company principally engaged in specialty medical hospitals, and occupational medicine. The business segments of the firm are Prachapat hospital, Occupational Medicine hospital and Environmental Analysis. Prachapat Hospital is engaged in rendering medical services to patients under government welfare schemes. Occupational Medicine Hospital is engaged in providing physical examination services. Majority of revenue is from Hospital Segment. Geographically, the company operates in Thailand.
70GF Score
Get the complete analysis for BKK:IMH-R
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:IMH-R has been successfully added to your 
